← ANALYSTS · TIPRANKS
Cory Kasimov · Evercore ISI
Hits
59%
290 of 491 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+18.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
23
Buy / hold / sell: 21 / 2 / 0
Upside of the analyst’s targets
+107.0%
Average over 23 current targets, to the last price
The market’s answer to the ratings
+2.3%
Day-0 move against SPY in the rating’s direction, average over 8 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks Oct 14 02:00 | ETRAElectra Therapeutics Inc. · $585M | Initiated | Buy | $36.00 | +311.4% | −7.6%next day +4.9% | ↗ |
| Oct 13on TipRanks 14:07 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $130 | +48.2% | −7.1%next day +0.7% | ↗ |
| Sep 29on TipRanks 09:11 | SMMTSummit Therapeutics · $12.4B | Reiterated | Buy | $34.00 | +132.4% | +6.1%next day +3.4% · 5 days +3.7% | ↗ |
| Sep 15on TipRanks 09:35 | BNTCIWMBenitec Biopharma · $289M | Reiterated | Buy | $25.00 | +208.3% | −8.1%next day +0.4% · 5 days −3.3% | ↗ |
| Sep 15on TipRanks 08:10 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $65.00 → $72.00+10.8% | +80.5% | −3.1%next day −0.8% · 5 days 0.0% | ↗ |
| Sep 14on TipRanks 09:15 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $130 | +95.8% | +0.4%next day −5.1% · 5 days −9.9% | ↗ |
| Sep 11on TipRanks 09:46 | MRNAQQQSPYModerna · $94.4B | Reiterated | Hold | $80.00 | −63.3% | +4.5%next day +2.3% · 5 days +7.1% | ↗ |
| Aug 31on TipRanks 09:15 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Buy | $325 | +40.3% | +1.8%next day +2.9% · 5 days +8.2% | ↗ |
| Aug 31on TipRanks 09:15 | CYTKIWMCytokinetics · $8.9B | Reiterated | Buy | $100 | +61.4% | −1.3%next day +1.4% · 5 days +6.4% | ↗ |
| Aug 27on TipRanks 08:00 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $230 → $320+39.1% | +79.8% | +2.0%next day −5.8% · 5 days −4.9% | ↗ |
| Aug 17on TipRanks 09:05 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $210 → $215+2.4% | +58.4% | +1.6%next day +0.5% · 5 days +0.3% | ↗ |
| Aug 12on TipRanks 09:45 | IMNMIWMImmunome · $2.1B | Reiterated | Buy | $40.00 | +142.9% | +6.4%next day −6.3% · 5 days +7.0% | ↗ |
| Aug 7on TipRanks 13:05 | XENEIWMXenon · $3.3B | Reiterated | Buy | $80.00 | +138.9% | −2.5%next day +1.4% · 5 days −2.0% | ↗ |
| Aug 7on TipRanks 08:45 | EWTXIWMEdgewise Therapeutics · $4.1B | Reiterated | Buy | $55.00 | +47.9% | −2.6%next day +2.5% · 5 days +1.1% | ↗ |
| Aug 7on TipRanks 08:45 | BMRNBioMarin Pharmaceutical · $10.8B | Reiterated | Buy | $120 | +119.5% | +3.2%next day +8.0% · 5 days +5.2% | ↗ |
| Aug 6on TipRanks 08:25 | VIRIWMVir Biotechnology · $1.8B | Reiterated | Buy | $22.00 | +120.9% | −3.6%next day 0.0% · 5 days +1.5% | ↗ |
| Aug 5on TipRanks 10:35 | BEAMIWMBeam Therapeutics · $2.6B | Reiterated | Buy | $45.00 | +91.7% | −4.3%next day +0.8% · 5 days −1.7% | ↗ |
| Aug 5on TipRanks 08:16 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $135 → $130−3.7% | +48.2% | +1.1%next day −0.9% · 5 days +0.3% | ↗ |
| Aug 4on TipRanks 10:34 | ORICIWMOric Pharmaceuticals · $1.3B | Reiterated | Buy | $25.00 | +102.4% | +25.3%next day −3.8% · 5 days +2.0% | ↗ |
| Aug 4on TipRanks 10:23 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | $535 | +7.1% | −0.1%next day +1.5% · 5 days +10.7% | ↗ |
| May 26on TipRanks Jun 3 07:31 | COAGIWMHemab Therapeutics Holdings, Inc. · $1.5B | Initiated | Buy | $50.00 | +66.3% | +6.9%next day +2.7% · 5 days −2.5% | ↗ |
| May 18on TipRanks 08:50 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Buy | $875 → $825−5.7% | +4.3% | −9.8%next day +0.8% · 5 days −0.7% | ↗ |
| Mar 27on TipRanks 06:50 | UPBIWMUpstream Bio, Inc. · $185M | Downgrade | Hold | $40.00 → $15.00−62.5% | +443.5% | −9.7%next day +1.6% · 5 days +8.2% | ↗ |
| Mar 17on TipRanks 09:45 | ZBIOIWMZenas BioPharma, Inc. · $1.7B | Reiterated | Buy | $55.00 | +121.4% | +0.8%next day −0.5% · 5 days −7.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗